Gynecologic Oncology
RSSArticles
-
The Aspirin Story in Reducing the Incidence of Preeclampsia
-
Hormone Therapy and In-Hospital Survival after Myocardial Infarction in Postmenopausal Women
-
Special Feature: Maintaining Board Certification
-
Clinical Briefs in Primary Care Supplement
-
XRT to Prevent Local Breast Cancer Recurrence: A Little More is Better
-
Ascites, Neoadjuvant Chemotherapy, and Ovarian Cancer
-
Clinical Staging and Chemoradiation for Early Stage Hodgkin’s Disease
-
Tamoxifen and Breast Cancer Incidence Among Women with Inherited Mutations in BRCA1 and BRCA2
-
HPV vaccine continues to be underutilized
According to new data from the Centers for Disease Control and Prevention's (CDC's) 2013 National Immunization Survey Teen, the number of girls and boys ages 13-17 years receiving human papillomavirus (HPV) vaccine remains unacceptably low, despite a slight increase in vaccination coverage since 2012. -
EC: Progress made, but challenges remain
Availability of emergency contraception (EC) has broadened since the FDA ruled that generic EC could be sold on store shelves and would no longer require proof of age.